Title : Efficacy and tolerability of a topical NSAID patch (local action transcutaneous flurbiprofen) and oral diclofenac in the treatment of soft-tissue rheumatism.

Pub. Date : 1997 Jan

PMID : 9132322






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A statistically significant difference was observed in favour of flurbiprofen LAT for the principal measure, namely the investigator"s opinion of overall change in clinical condition: 49/53 (92%) patients treated with flurbiprofen LAT had improved by day 14 compared with 36/49 (73%) patients receiving diclofenac sodium (p = 0.03; eligible dataset). Flurbiprofen linker for activation of T cells Homo sapiens
2 A statistically significant difference was observed in favour of flurbiprofen LAT for the principal measure, namely the investigator"s opinion of overall change in clinical condition: 49/53 (92%) patients treated with flurbiprofen LAT had improved by day 14 compared with 36/49 (73%) patients receiving diclofenac sodium (p = 0.03; eligible dataset). Flurbiprofen linker for activation of T cells Homo sapiens
3 A statistically significant difference was observed in favour of flurbiprofen LAT for the principal measure, namely the investigator"s opinion of overall change in clinical condition: 49/53 (92%) patients treated with flurbiprofen LAT had improved by day 14 compared with 36/49 (73%) patients receiving diclofenac sodium (p = 0.03; eligible dataset). Flurbiprofen linker for activation of T cells Homo sapiens
4 Of the patients receiving flurbiprofen LAT, 94% regarded it as a convenient form of treatment. Flurbiprofen linker for activation of T cells Homo sapiens
5 In conclusion, local treatment of soft-tissue rheumatism with flurbiprofen LAT was demonstrably superior to benchmark oral therapy with diclofenac sodium over a 2-week period in terms of both efficacy and gastrointestinal tolerability. Flurbiprofen linker for activation of T cells Homo sapiens
6 Flurbiprofen LAT provided both an effective and convenient form of topical SAID treatment. Flurbiprofen linker for activation of T cells Homo sapiens